#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Stephen Burbidge Email
Head Research and Discovery . rewindtherapeutics.com
Heverlee,
Locations***************@rewindtherapeutics.com
Primary EmailHow to contact Stephen Burbidge
Join and see Stephen's contact info for free!Current Roles
Employees:
26Revenue:
$4MAbout
Rewind Therapeutics is a privately held Belgian biotech company that recently completed a €15.2 million Series A financing to develop novel re-myelinating therapies for patients suffering from multiple sclerosis and other myelin-related diseases. The round was led by experienced life science investors Boehringer Ingelheim Venture Fund (BIVF), M Ventures BV (MV) and Participatiemaatschappij Vlaanderen (PMV), together with KU Leuven's Centre for Drug Design and Discovery (CD3) and KU Leuven Gemma Frisius Fonds (GFF). The company currently focuses on bringing its first proprietary small molecule product to the clinic and to further expand its pipeline of novel drug candidates targeting myelin disorders. Rewind Therapeutics is founded by CD3 (Leuven, Belgium) and Axxam S.p.A. (Milano, Italy). In close collaboration with both organizations and a world-class academic network, Rewind Therapeutics aspires to advance innovative first-in-class therapies for myelin-related diseases into fast track clinical application.rewindtherapeutics.com Address
Gaston Geenslaan 2Heverlee, null